Achieved first full year of positive GAAP EPS since 2014 IPO, marking a transition from a growth-at-all-costs model to sustainable profitability.

Expanded from an ambulatory-focused provider to a care continuum company through the strategic acquisition of Medsphere, adding inpatient and emergency department capabilities.

Leveraged a 500% increase in free cash flow over three years to fund four 2025 acquisitions entirely from operations without common shareholder dilution.

Launched the stratusAI Front Desk Agent in December 2025 to address the multibillion-dollar addressable market for autonomous patient interaction and administrative automation.

Simplified the capital structure by converting 80% of Series A preferred shares to common, eliminating over $7 million in annual dividend obligations.

Utilized a disciplined M&A playbook targeting recurring revenue portfolios at valuations of 1x revenue or less to drive inorganic growth and cross-sell opportunities.

Established the AI Center of Excellence to develop proprietary, healthcare-specific models that integrate directly into clinical workflows rather than relying on generic AI.

Guidance for 2026 projects GAAP EPS of $0.20 to $0.23, representing a potential increase of more than 100% over 2025 levels.

Strategic focus shifts to 'execution mode' for AI, prioritizing the monetization of the stratusAI suite and the integration of AI-assisted coding and prior authorization tools.

Management expects to remain active in M&A during 2026, targeting complementary firms that can benefit from CareCloud's AI-driven margin expansion playbook.

Growth strategy centers on penetrating the newly acquired hospital and health system customer base with high-margin RCM services and AI products.

Assumes continued margin expansion driven by shifting from human-led back-office processing to 'zero-touch' automated claims workflows.

Resumed preferred share dividends and initiated double payments on Series B preferred stock to address accumulated arrearages.

Fully repaid the Provident Bank credit line by year-end 2025, entering 2026 with $10 million in available liquidity and zero debt drawn.

Management identifies a competitive moat in proprietary data from hundreds of millions of claims, which protects against disruption from horizontal SaaS AI entrants.

The HFMA partnership for the MAP App provides a strategic distribution channel into hospital finance leadership that would otherwise take years to build.

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.

Management targets acquiring underperforming companies at 0.6x to 1x revenue and applying an AI overlay to reach 25% to 30% profitability margins within 9 months.

AI is used to replace manual back-office functions, allowing the company to grow revenue while maintaining or reducing total headcount.

Management argues that healthcare IT has deep moats due to HIPAA compliance, government certifications, and the 'system of record' status that generic AI agents lack.

While horizontal players like SoundHound have high valuations, CareCloud claims a superior vertical advantage by owning the EHR platform where the data resides.

The stratusAI Front Desk Agent is already handling approximately 80% of inbound scheduling calls for early-adopter practices.

Sales efforts are currently focused on the existing ambulatory base, with plans to aggressively target the Medsphere hospital client base later in 2026.

One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.